The "Solid State Laboratory" project aims to expand the research and development capabilities of FARMAK, a.s., focusing on the development of new generic active pharmaceutical ingredients (APIs), the study of their various crystalline forms, and the subsequent optimization of production based on the acquired know-how. The project focuses on implementing advanced technologies in the field of solid-state drug chemistry, which includes investigating the relationships between the crystalline form of an API and its impact on drug solubility, stability, and bioavailability.